Company news
Botanix Pharmaceuticals Limited news in 2019
Botanix Pharmaceuticals Limited's news releases, calls and decks from 2019, newest first.
Botanix Initiates BTX 1702 Rosacea Study
December 8, 2019
Botanix Announces De-scheduling of Synthetic CBD
November 24, 2019
Botanix Announces BTX 1503 Data and Progression to Phase 3
October 22, 2019
BOT Receives Grant for Synthetic Cannabidiol Analog Program
October 14, 2019
Botanix announces new clinical program to target rosacea
September 15, 2019
Appendix 4E and Annual Report
August 19, 2019
Botanix $40 Million US Lead Placement and Management Update
July 31, 2019
Botanix Antimicrobial Platform Addresses Global Threat
July 14, 2019
BTX 1801 Kills Superbugs Without Resistance World-First
June 19, 2019
Study Confirms Anti-inflammatory and Other Properties of CBD
June 18, 2019
Pause in Trade
June 17, 2019
Dermatology Industry Leader Joins Botanix
May 19, 2019
Botanix Provides Retraction in Presentation
May 16, 2019
Pause In Trading
May 15, 2019
Permetrex Outperforms Other CBD Topical Products
February 25, 2019
Investigators Meeting Completed for BTX 1204 Phase 2 Study
January 24, 2019
Decks in 2019
- Non-Deal Roadshow (December 2019)
Roadshow · 27 slides · Dec 9, 2019
- Shareholder Meeting (October 2019)
Shareholder meeting · 23 slides · Oct 28, 2019
- Technical Presentation (October 2019)
Technical · 14 slides · Oct 23, 2019
- Investor Presentation (September 2019)
Investor deck · 33 slides · Sep 17, 2019
- Investor Presentation (June 2019)
Investor deck · 36 slides · Jun 20, 2019
- Investor Presentation (June 2019)
Investor deck · 19 slides · Jun 14, 2019
- Jefferies Healthcare Conference 2019
Conference · 30 slides · Jun 6, 2019
- Investor Presentation (March 2019)
Investor deck · 20 slides · Mar 4, 2019
- Investor Presentation (January 2019)
Investor deck · 34 slides · Jan 31, 2019